Catalyst Wire Dossier Catalyst Wire Dossier

HRS-7053 injection

HRS-7053 · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-7053 injection, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of HRS-7053 Injection in the Treatment of Patients With Advanced Malignancies [Phase 1]

See pricing